Case Study: S&P 500 Pharmaceuticals Company accelerates vendor assessments and saves one week per assessment with Prevalent

S&P 500 Pharmaceuticals Company - Customer Case Study

S&P 500 Pharmaceuticals Company turned to Prevalent’s third‑party risk management solution to strengthen cybersecurity and reduce the operational burden of vendor assessments. The company was struggling with manual collection and analysis of vendor surveys, no centralized TPRM functions, inconsistent vendor risk methodologies, and the need to meet requirements such as GDPR, HIPAA, ISO 27001 and NIST 800‑53.

Prevalent implemented its Platform to automate survey collection, scheduling and reminders, enable in‑solution supplier communication, create tasks/flags/risks, scan third‑party networks for outside‑in risk scoring, and provide consolidated dashboards. As a result, the company cut assessment time from 3–4 weeks to 1–2 weeks—saving about one week per assessment—and rated several Prevalent capabilities as very highly differentiated versus competitors.